Patents by Inventor Alex M. Dickens

Alex M. Dickens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosing a brain tumour in a human
    Patent number: 10859576
    Abstract: An in vitro method for diagnosing a brain tumour in a human test subject comprising: determining the concentration of at least two metabolites comprised in a biofluid sample obtained from the human test subject; comparing the concentration of the at least two metabolites in the biofluid sample with the concentration of the same at least two metabolites in at least one reference standard obtained from a non-tumour bearing subject and/or a tumour bearing subject; and identifying a concentration difference for each of the at least two metabolites in the biofluid sample relative to the reference standard; wherein the concentration difference for each of the at least two metabolites in the biofluid sample correlates with the presence of a brain tumour. The invention also relates to a data-storage medium comprising data obtained by a method of the invention.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: December 8, 2020
    Assignee: Oxford University Innovation Limited
    Inventors: Nicola R. Sibson, Daniel C. Anthony, Alex M. Dickens, James R. Larkin
  • METHOD FOR DIAGNOSING A BRAIN TUMOUR IN A HUMAN
    Publication number: 20180172688
    Abstract: An in vitro method for diagnosing a brain tumour in a human test subject comprising: determining the concentration of at least two metabolites comprised in a biofluid sample obtained from the human test subject; comparing the concentration of the at least two metabolites in the biofluid sample with the concentration of the same at least two metabolites in at least one reference standard obtained from a non-tumour bearing subject and/or a tumour bearing subject; and identifying a concentration difference for each of the at least two metabolites in the biofluid sample relative to the reference standard; wherein the concentration difference for each of the at least two metabolites in the biofluid sample correlates with the presence of a brain tumour. The invention also relates to a data-storage medium comprising data obtained by a method of the invention.
    Type: Application
    Filed: June 3, 2016
    Publication date: June 21, 2018
    Applicant: Oxford University Innovation Limited
    Inventors: Nicola R. Sibson, Daniel C. Anthony, Alex M. Dickens, James R. Larkin